Search hospitals > North Carolina > Durham
Duke Eye Center
Claim this profileDurham, North Carolina 27701
Global Leader in Age-Related Macular Degeneration
Global Leader in Glaucoma
Conducts research for Retinal Disease
Conducts research for Macular Edema
Conducts research for Retinitis Pigmentosa
108 reported clinical trials
15 medical researchers
Summary
Duke Eye Center is a medical facility located in Durham, North Carolina. This center is recognized for care of Age-Related Macular Degeneration, Glaucoma, Retinal Disease, Macular Edema, Retinitis Pigmentosa and other specialties. Duke Eye Center is involved with conducting 108 clinical trials across 107 conditions. There are 15 research doctors associated with this hospital, such as Lejla Vajzovic, MD, Sharon F Freedman, MD, Cynthia A Toth, MD, and Mays Dairi, MD.Area of expertise
1Age-Related Macular Degeneration
Global LeaderStage I
Stage II
CFI rare variant positive
2Glaucoma
Global LeaderTop PIs
Lejla Vajzovic, MDDuke Eye Center1 year of reported clinical research
Studies Retinal Disease
Studies Retinitis
7 reported clinical trials
8 drugs studied
Sharon F Freedman, MDDuke University Eye Center2 years of reported clinical research
Studies Retinal Disease
Studies Premature Birth
5 reported clinical trials
5 drugs studied
Cynthia A Toth, MDDuke University Eye Center8 years of reported clinical research
Studies Retinal Disease
Studies Retinopathy of Prematurity
4 reported clinical trials
5 drugs studied
Mays Dairi, MDDuke University Eye Center1 year of reported clinical research
Studies Nervous System Disorders
Studies Optic Neuropathy
2 reported clinical trials
1 drug studied
Clinical Trials running at Duke Eye Center
Age-Related Macular Degeneration
Retinal Detachment
Glaucoma
Retinal Disease
Premature Birth
Retinopathy of Prematurity
Diabetic Retinopathy
Macular Edema
Stargardt Disease
Convergence Insufficiency
RGX-314 Gene Therapy
for Age-Related Macular Degeneration
This trial is testing a new one-time gene therapy called RGX-314 for patients with wet AMD. The goal is to reduce the need for regular treatments by helping the eye produce its own protective proteins. This could make treatment easier and more effective for patients.
Recruiting2 awards Phase 32 criteria
OCU410
for Age-Related Macular Degeneration
This trial tests OCU410, a gene therapy injected into the eye, for patients with severe vision loss due to advanced dry AMD. The treatment uses a virus to deliver helpful genes that may restore normal eye function.
Recruiting1 award Phase 1 & 27 criteria
OCU410ST
for Stargardt Disease
This trial tests OCU410ST, a treatment using a harmless virus to deliver a helpful gene into the eye, for children and young adults with Stargardt disease. The gene helps manage fat buildup, stress, and inflammation in the eye.
Recruiting1 award Phase 1 & 2
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Duke Eye Center?
Duke Eye Center is a medical facility located in Durham, North Carolina. This center is recognized for care of Age-Related Macular Degeneration, Glaucoma, Retinal Disease, Macular Edema, Retinitis Pigmentosa and other specialties. Duke Eye Center is involved with conducting 108 clinical trials across 107 conditions. There are 15 research doctors associated with this hospital, such as Lejla Vajzovic, MD, Sharon F Freedman, MD, Cynthia A Toth, MD, and Mays Dairi, MD.